Comprehensive Evaluation of the m(6)A Regulator Prognostic Risk Score in the Prediction of Immunotherapy Response in Clear Cell Renal Cell Carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is known for its high drug resistance. The tumor-immune crosstalk mediated by the epigenetic regulation of N6-methyladenosine (m(6)A) modification has been demonstrated in recent studies. Therefore, m(6)A modification-mediated immune cell infiltrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Mingke, Liu, Xuefei, Xu, Han, Shen, Sangyu, Wang, Fajiu, Chen, Dajin, Li, Guorong, Wang, Zongping, Zuo, Zhixiang, Zhao, An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248360/
https://www.ncbi.nlm.nih.gov/pubmed/35784363
http://dx.doi.org/10.3389/fimmu.2022.818120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248360/
https://www.ncbi.nlm.nih.gov/pubmed/35784363
http://dx.doi.org/10.3389/fimmu.2022.818120

Ejemplares similares